Antibody-dependent cellular cytotoxicity

Antibodies
#Antibody drug conjugate (ADC) #Antibody-dependent cellular cytotoxicity #Case study #Drug discovery #Flow Cytometry

Case Study: ADC synthesis, development, and characterisation

A new Case Study is now available from Eurofins Discovery entitled ‘Synthesis & characterization of trastuzumab-based ADCs using fluorescent & cytotoxic payloads‘. Delve into these case studies on ADC synthesis, development, and characterisation, where we reveal how: Trastuzumab-based ADCs with multiple payload linkers demonstrated specific, targeted functional activity. Flow… Read More

#News

#Antibody drug conjugate (ADC) #Antibody-dependent cellular cytotoxicity #Drug discovery #Flow Cytometry

Synthesis & characterisation of trastuzumab-based ADCs using fluorescent & cytotoxic payloads

Delve into these case studies on ADC synthesis, development, and characterisation, where we reveal how: Trastuzumab-based ADCs with multiple payload linkers demonstrated specific, targeted functional activity. Flow cytometry and internalisation assays confirmed antigen targeting and cellular uptake. Cytotoxicity assays revealed nanomolar IC50s only in HER2+ cell lines, confirming ADC efficacy… Read More

#Resources

Antibodies
#Afucosylated mAb expression #Antibody #Antibody-dependent cellular cytotoxicity #Glycoengineered antibodies #Monoclonal antibodies

New App Note: Afucosylated mAb expression and antibody efficacy

Currently, at least 35 glycoengineered antibodies, with their Fc fucose partially or entirely removed, have been investigated in animal models or clinical trials. The absence of fucose on the Fc N-glycan increases IgG1 Fc binding affinity to the FcγRIIIa on immune effector cells like natural killer cells. It results in… Read More

#News

#Afucosylated mAb expression #Antibody #Antibody-dependent cellular cytotoxicity #Glycoengineered antibodies

Afucosylated mAb expression benefits therapeutic antibody efficacy

Currently, at least 35 glycoengineered antibodies, with their Fc fucose partially or entirely removed, have been investigated in animal models or clinical trials. The absence of fucose on the Fc N-glycan increases IgG1 Fc binding affinity to the FcγRIIIa on immune effector cells like natural killer cells. It results in… Read More

#App Notes #Intelligence #Resources